Bik stabilization by blocking ASB11-mediated degradation appears to amplify Bik’s apoptotic activity, suggesting that modulating this pathway could enhance responses to cancer treatments in TNBC and potentially in other cancer types. This evidence concerns the gene BIK and cancer.